Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Biomarker-guided treatment of CLL in the chemo-free era
06:54
|
Download MP3
Related Videos
2:13
Personalizing the timing of SCT in patients with myelofibrosis
1:31
Frontline treatment for CLL: the changing paradigm
0:44
Early detection and interception across hematological cancers
6:54
Biomarker-guided treatment of CLL in the chemo-free era
2:55
A model including CD49d expression to predict outcomes in patients with CLL treated with ibrutinib
0:52
Genomic profiling at diagnosis of myeloid neoplasms
1:36
The use of outpatient cilta-cel in the treatment of multiple myeloma
1:53
Challenges in developing immunotherapies for CLL compared to other hematologic malignancies
3:40
Master class in transplantation and hematology: highlights
5:40
Recommendations for biomarker analysis in CLL: updates from ERIC 2024
3:26
New approaches to treating transplant-ineligible multiple myeloma: triplets and quadruplets
1:18
Targeted therapies in R/R myeloma: novel approaches being explored
2:07
Challenges associated with the management of extramedullary myeloma & ongoing research
1:14
Promising novel agents in AML: menin inhibitors
3:02
The role of asparaginase in the treatment of ALL
2:26
An insight into the aims of the Eurasian Hematology-Oncology Group
1:15
The diagnosis and management of MDS/MPN with neutrophilia (atypical CML)
1:15
The value of early diagnosis in amyloidosis and the impact of a delayed diagnosis for patients
0:51
Predicting which patients with SMM will progress to multiple myeloma
1:22
Responses to olutasidenib in patients with AML who have failed treatment with venetoclax
2:13 1:31 0:44 6:54 2:55 0:52 1:36 1:53 3:40 5:40 3:26 1:18 2:07 1:14 3:02 2:26 1:15 1:15 0:51 1:22
